We are live on
!
Find out more
ETM
Euclidean Technologies Management Portfolio holdings
AUM
$109M
1-Year Est. Return
7.18%
This Fund
S&P 500
This Quarter
Est. Return
-6.9%
1 Year Est. Return
+7.18%
3 Year Est. Return
+123.73%
5 Year Est. Return
+76.06%
10 Year Est. Return
–
AUM
$108M
AUM Growth
-$11.3M
(-9.4%)
Cap. Flow
-$2.11M
Cap. Flow
% of AUM
-1.95%
Top 10 Holdings %
Top 10 Hldgs %
22.24%
Holding
102
New
12
Increased
13
Reduced
14
Closed
19
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Insteel Industries
IIIN
|
+$2.01M |
| 2 |
Covenant Logistics
CVLG
|
+$1.98M |
| 3 |
Titan Machinery
TITN
|
+$964K |
| 4 |
HIBB
Hibbett, Inc. Common Stock
HIBB
|
+$921K |
| 5 |
REX American Resources
REX
|
+$911K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RE/MAX Holdings
RMAX
|
+$1.7M |
| 2 |
Cabot Corp
CBT
|
+$1.52M |
| 3 |
ePlus
PLUS
|
+$1.35M |
| 4 |
VIVO
Meridian Bioscience Inc
VIVO
|
+$1.06M |
| 5 |
DXP Enterprises
DXPE
|
+$968K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 39.13% |
| 2 | Consumer Discretionary | 23.98% |
| 3 | Consumer Staples | 14.98% |
| 4 | Technology | 9.9% |
| 5 | Healthcare | 5.02% |
Similar funds
CWM
ACM
RA
AMC
BCM
HLCM
TWP
PCM
Euclidean Technologies Management's Q1 2022 Portfolio in Review
As of Q1 2022, Euclidean Technologies Management held 102 positions worth $108M, down 9.4% from $120M the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Euclidean Technologies Management's Q1 2022 filing shows 12 new, 13 increased, 14 reduced and 19 closed positions. Its largest new stake was Insteel Industries: 51,906 shares worth $1.92M. The largest sale was RE/MAX Holdings, an estimated $1.7M.
By sector, the portfolio is most concentrated in Industrials at 39% of assets, up from 35% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.
- Euclidean Technologies Management's largest Q1 2022 buy was Insteel Industries: 51,906 shares worth $1.92M.
- Euclidean Technologies Management added most to Hibbett, Inc. Common Stock in Q1 2022, an estimated $921K increase.
- Euclidean Technologies Management's biggest Q1 2022 reduction was Meridian Bioscience Inc, cutting an estimated $1.06M.
- Euclidean Technologies Management fully exited RE/MAX Holdings in Q1 2022, selling an estimated $1.7M.
- Euclidean Technologies Management's ten largest holdings make up 22% of its $108M portfolio in Q1 2022.
- Euclidean Technologies Management opened 12 new positions and closed 19 in Q1 2022.
- Euclidean Technologies Management's portfolio value fell 9.4% quarter-over-quarter to $108M.
Based on Euclidean Technologies Management's 13F filing for Q1 2022, filed 28 Apr 2022.